2-(2,6-dioxopiperidin-3-yl)-5-[4-[[(4R)-4-[[4-[6-[5-(1-methylcyclopropyl)oxy-1H-indazol-3-yl]pyrimidin-4-yl]piperazin-1-yl]methyl]-2-oxopiperidin-1-yl]methyl]piperidin-1-yl]isoindole-1,3-dione;molecular hydrogen
C44H54N10O6 — CID 165137852
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(2,6-dioxopiperidin-3-yl)-5-[4-[[(4R)-4-[[4-[6-[5-(1-methylcyclopropyl)oxy-1H-indazol-3-yl]pyrimidin-4-yl]piperazin-1-yl]methyl]-2-oxopiperidin-1-yl]methyl]piperidin-1-yl]isoindole-1,3-dione;molecular hydrogen
2-(2,6-dioxopiperidin-3-yl)-5-[4-[[(4R)-4-[[4-[6-[5-(1-methylcyclopropyl)oxy-1H-indazol-3-yl]pyrimidin-4-yl]piperazin-1-yl]methyl]-2-oxopiperidin-1-yl]methyl]piperidin-1-yl]isoindole-1,3-dione;molecular hydrogen (PubChem CID 165137852) has the molecular formula C44H54N10O6 and a molecular weight of 818.98 g/mol. Its IUPAC name is 2-(2,6-dioxopiperidin-3-yl)-5-[4-[[(4R)-4-[[4-[6-[5-(1-methylcyclopropyl)oxy-1H-indazol-3-yl]pyrimidin-4-yl]piperazin-1-yl]methyl]-2-oxopiperidin-1-yl]methyl]piperidin-1-yl]isoindole-1,3-dione;molecular hydrogen.
Molecular Properties
| Compound Name | 2-(2,6-dioxopiperidin-3-yl)-5-[4-[[(4R)-4-[[4-[6-[5-(1-methylcyclopropyl)oxy-1H-indazol-3-yl]pyrimidin-4-yl]piperazin-1-yl]methyl]-2-oxopiperidin-1-yl]methyl]piperidin-1-yl]isoindole-1,3-dione;molecular hydrogen |
|---|---|
| PubChem CID | 165137852 |
| Molecular Formula | C44H54N10O6 |
| Molecular Weight | 818.98 g/mol |
| Exact Mass | 818.42 |
| IUPAC Name | 2-(2,6-dioxopiperidin-3-yl)-5-[4-[[(4R)-4-[[4-[6-[5-(1-methylcyclopropyl)oxy-1H-indazol-3-yl]pyrimidin-4-yl]piperazin-1-yl]methyl]-2-oxopiperidin-1-yl]methyl]piperidin-1-yl]isoindole-1,3-dione;molecular hydrogen |
| SMILES | CC1(Oc2ccc3[nH]nc(-c4cc(N5CCN(C[C@@H]6CCN(CC7CCN(c8ccc9c(c8)C(=O)N(C8CCC(=O)NC8=O)C9=O)CC7)C(=O)C6)CC5)ncn4)c3c2)CC1.[H][H].[H][H] |
| InChI | InChI=1S/C44H50N10O6.2H2/c1-44(11-12-44)60-30-3-5-34-33(22-30)40(49-48-34)35-23-37(46-26-45-35)52-18-16-50(17-19-52)24-28-10-15-53(39(56)20-28)25-27-8-13-51(14-9-27)29-2-4-31-32(21-29)43(59)54(42(31)58)36-6-7-38(55)47-41(36)57;;/h2-5,21-23,26-28,36H,6-20,24-25H2,1H3,(H,48,49)(H,47,55,57);2*1H/t28-,36?;;/m1../s1 |
| InChIKey | KFIAFJWJAWJEBN-RRYGWHIZSA-N |
| XLogP | 4.12 |
| TPSA | 177.27 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 60 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 818.98 |
| LogP ≤ 5 | 4.12 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 12 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 165137852 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.